Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its "Abuse and Misuse Deterrent Transdermal System" Application
Dec 31, 2021
Nutriband Inc. Announces $1 Million Share Repurchase Authorization
Dec 29, 2021
Nutriband Inc. Initiates Plans to Offer Topical Lotion Contract Manufacturing Services
Dec 21, 2021
Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary
Dec 13, 2021
Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021
Dec 3, 2021
Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) Fentanyl
Nov 16, 2021
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
Nov 10, 2021
Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7M
Oct 22, 2021
Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch
Oct 12, 2021
Nutriband Inc.'s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO)
Oct 4, 2021